Dr. Nora Jane Bucher, MD

Dr. Bucher practices at Compass Oncology in Vancouver, Washington.

Dr. Bucher's NPI, 1942416524, was assigned on May 14, 2007. Dr. Bucher graduated from University of Illinois College of Medicine - Chicago in 2001. Dr. Bucher's Washington license number on file is MD.60932574.

Dr. Bucher's primary practice is Compass Oncology, at 210 Se 136th Ave, Vancouver, WA 98684-6930. The practice phone is (360) 944-9889.

Dr. Bucher's primary practice is Compass Oncology in Vancouver, Washington. Dr. Bucher is also affiliated with Legacy Salmon Creek Medical Center. The medical group on file is Compass Oncology. Dmand AI also links Dr. Bucher to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bucher practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bucher's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bucher is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Bucher's licenses on file in 4 states: Washington, California, Oregon and Illinois.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, lung cancer, lymphoma, multiple myeloma, neutropenia and prostate cancer among the conditions Dr. Bucher treats.

CMS data shows 16,409 Medicare services from Dr. Bucher across 34 procedure codes in 2024, for 258 Medicare patients. Medicare paid $102,669 for them. Every service was in an office.

CMS counts 258 Medicare patients who saw Dr. Bucher in 2024. The largest group is 65 to 74, with 142 patients. 62% of them have cancer, and 61% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bucher's median patient age at 64, with 81% women.

In 2024, Dr. Bucher wrote 1,539 Medicare Part D claims for 193 patients. 88% of them were for generic drugs. CMS names the drug for 1,169 of them, across 40 drugs with 11 or more claims each, at $1,098,090 in total drug cost. In 2023, CMS named 1,087 claims across 36 drugs.

Dr. Bucher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bucher as offering telehealth.

Dmand AI links 3 papers to Dr. Bucher in 2013. 2013 was the busiest year, with 2. Dr. Bucher has published most often in BMJ Case Rep. Dr. Bucher's most frequent co-author is Anna Gabrielian, MD.

CMS Open Payments shows 331 general payments to Dr. Bucher from 40 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 48% of the total. Stemline Therapeutics Inc. paid the most, $46,459.

Dmand AI lists 1 award for Dr. Bucher, most recently CMS Stage 1 EHR in 2013.

Dr. Bucher graduated from University of Illinois College of Medicine - Chicago in 2001. Dr. Bucher is a member of ASCO.

Dr. Bucher is in network with 17 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.